{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:37:37Z","timestamp":1790775457985,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["LHDMD24H030001"],"award-info":[{"award-number":["LHDMD24H030001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81870564"],"award-info":[{"award-number":["81870564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17406-2","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T15:34:51Z","timestamp":1756395291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune metabolic changes identify causal candidate genes and enable diagnostic frameworks in MAFLD"],"prefix":"10.1038","volume":"15","author":[{"given":"Jie","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-You","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Fei","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"issue":"4","key":"17406_CR1","first-page":"e855","volume":"20","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. The health impact of MAFLD, a novel disease cluster of NAFLD, is amplified by the integrated effect of fatty liver disease-Related genetic Variants[J]. clinical gastroenterology and hepatology: the official clinical practice. J. Am. Gastroenterological Association. 20 (4), e855\u2013e875 (2022).","journal-title":"J. Am. Gastroenterological Association"},{"issue":"1","key":"17406_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes[J].  Hepatol. 64 (1), 73\u201384 (2016).","journal-title":"Hepatol."},{"issue":"4","key":"17406_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang, D. Q., El-Serag, H. B. & Loomba, R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention[J]. Nat. Rev. Gastroenterol. Hepatol. 18 (4), 223\u2013238 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"17406_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","volume":"22","author":"T Huby","year":"2022","unstructured":"Huby, T. & Gautier, E. L. Immune cell-mediated features of non-alcoholic steatohepatitis[J]. Nat. Rev. Immunol. 22 (7), 429\u2013443 (2022).","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"17406_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","volume":"17","author":"S Sutti","year":"2020","unstructured":"Sutti, S. & Albano, E. Adaptive immunity: an emerging player in the progression of NAFLD[J]. Nat. Rev. Gastroenterol. Hepatol. 17 (2), 81\u201392 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"17406_CR6","doi-asserted-by":"publisher","first-page":"e54271","DOI":"10.15252\/embr.202154271","volume":"23","author":"CY Ng","year":"2022","unstructured":"Ng, C. Y. et al. Endothelial-immune crosstalk contributes to vasculopathy in nonalcoholic fatty liver disease[J]. EMBO Rep. 23 (6), e54271 (2022).","journal-title":"EMBO Rep."},{"issue":"9","key":"17406_CR7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41419-023-06146-8","volume":"14","author":"BC Sim","year":"2023","unstructured":"Sim, B. C. et al. Hepatic T-cell senescence and exhaustion are implicated in the progression of fatty liver disease in patients with type 2 diabetes and mouse model with nonalcoholic steatohepatitis[J]. Cell Death Dis. 14 (9), 618 (2023).","journal-title":"Cell Death Dis."},{"issue":"3","key":"17406_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jhep.2024.04.009","volume":"81","author":"JT Fu","year":"2024","unstructured":"Fu, J. T. et al. Targeting EFHD2 inhibits interferon-\u03b3 signaling and ameliorates non-alcoholic steatohepatitis[J]. J. Hepatol. 81 (3), 389\u2013403 (2024).","journal-title":"J. Hepatol."},{"issue":"11","key":"17406_CR9","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula, P. et al. Mendelian randomization as an approach to assess causality using observational Data[J]. J. Am. Soc. Nephrology: JASN. 27 (11), 3253\u20133265 (2016).","journal-title":"J. Am. Soc. Nephrology: JASN"},{"issue":"2","key":"17406_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage[J]. Nat. Immunol. 20 (2), 163\u2013172 (2019).","journal-title":"Nat. Immunol."},{"key":"17406_CR11","unstructured":"GTEx Consortium. The GTEx Consortium Atlas of Genetic Regulatory Effects across Human tissues[J]3691318\u20131330 (Science, 2020). (New York, N.Y.)6509."},{"issue":"9","key":"17406_CR12","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa, U. et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression[J]. Nat. Genet. 53 (9), 1300\u20131310 (2021).","journal-title":"Nat. Genet."},{"issue":"11","key":"17406_CR13","doi-asserted-by":"publisher","first-page":"100437","DOI":"10.1016\/j.xcrm.2021.100437","volume":"2","author":"N Ghodsian","year":"2021","unstructured":"Ghodsian, N. et al. Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease[J]. Cell. Rep. Med. 2 (11), 100437 (2021).","journal-title":"Cell. Rep. Med."},{"issue":"4","key":"17406_CR14","doi-asserted-by":"publisher","first-page":"G462","DOI":"10.1152\/ajpgi.00358.2018","volume":"316","author":"MP Suppli","year":"2019","unstructured":"Suppli, M. P. et al. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals[J]. Am. J. Physiol. Gastrointest. Liver. Physiol. 316 (4), G462\u2013G472 (2019).","journal-title":"Am. J. Physiol. Gastrointest. Liver. Physiol."},{"issue":"5","key":"17406_CR15","doi-asserted-by":"publisher","first-page":"e0124544","DOI":"10.1371\/journal.pone.0124544","volume":"10","author":"I Frades","year":"2015","unstructured":"Frades, I. et al. Integrative genomic signatures of hepatocellular carcinoma derived from nonalcoholic fatty liver disease[J]. PloS One. 10 (5), e0124544 (2015).","journal-title":"PloS One"},{"issue":"7","key":"17406_CR16","doi-asserted-by":"publisher","first-page":"e00466","DOI":"10.14309\/ctg.0000000000000466","volume":"13","author":"P Pettinelli","year":"2022","unstructured":"Pettinelli, P. et al. Relationship between hepatic gene expression, intestinal microbiota, and inferred functional metagenomic analysis in NAFLD[J]. Clin. Translational Gastroenterol. 13 (7), e00466 (2022).","journal-title":"Clin. Translational Gastroenterol."},{"key":"17406_CR17","doi-asserted-by":"publisher","first-page":"1243526","DOI":"10.3389\/fimmu.2024.1243526","volume":"15","author":"RW Niedecker","year":"2024","unstructured":"Niedecker, R. W. et al. Investigating peripheral blood monocyte and T-cell subsets as non-invasive biomarkers for asymptomatic hepatic steatosis: results from the Multi-Ethnic study of Atherosclerosis[J]. Front. Immunol. 15, 1243526 (2024).","journal-title":"Front. Immunol."},{"issue":"4","key":"17406_CR18","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","volume":"77","author":"M Peiseler","year":"2022","unstructured":"Peiseler, M. et al. Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits[J]. J. Hepatol. 77 (4), 1136\u20131160 (2022).","journal-title":"J. Hepatol."},{"issue":"4","key":"17406_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/hep4.1041","volume":"1","author":"J Bhattacharjee","year":"2017","unstructured":"Bhattacharjee, J. et al. Hepatic natural killer T-cell and CD8\u2009+\u2009T-cell signatures in mice with nonalcoholic Steatohepatitis[J]. Hepatol. Commun. 1 (4), 299\u2013310 (2017).","journal-title":"Hepatol. Commun."},{"issue":"4","key":"17406_CR20","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1002\/hep.31875","volume":"74","author":"WM Choi","year":"2021","unstructured":"Choi, W. M. et al. Metabotropic glutamate receptor 5 in natural killer cells attenuates liver fibrosis by exerting cytotoxicity to activated stellate cells[J]. Hepatol. 74 (4), 2170\u20132185 (2021).","journal-title":"Hepatol."},{"key":"17406_CR21","doi-asserted-by":"crossref","unstructured":"Rau, M. et al. Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17\/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver[J]. Journal of Immunology (Baltimore, Md.: 2016, 196(1): 97\u2013105. (1950).","DOI":"10.4049\/jimmunol.1501175"},{"issue":"7","key":"17406_CR22","doi-asserted-by":"publisher","first-page":"8490","DOI":"10.1096\/fj.201802534RR","volume":"33","author":"T Wang","year":"2019","unstructured":"Wang, T. et al. The immunoregulatory effects of CD8 T-cell-derived Perforin on diet-induced nonalcoholic steatohepatitis[J]. FASEB Journal: Official Publication Federation Am. Soc. Experimental Biology. 33 (7), 8490\u20138503 (2019).","journal-title":"FASEB Journal: Official Publication Federation Am. Soc. Experimental Biology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17406-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17406-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17406-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:07:41Z","timestamp":1757480861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17406-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17406"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17406-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"31751"}}